The global herpes markers testing market is expected to grow at a CAGR of 6.1%, reaching US$ 817.5 million by 2034. The rise in herpes infections is driving significant market expansion, with the market projected to hit US$ 452.9 million by 2024.
It is anticipated that the strong pipeline and ongoing R&D efforts would offer the worldwide herpes marker testing market exceptional growth potential. Between 2024 and 2034, these factors will give market participants a lot of opportunities to leverage and grow their companies.
Herpes marker testing is necessary due to the increasing incidence of the herpes simplex virus, specifically HSV-1 and HSV-2. According to the Public Health Agency of Canada’s research, the seroprevalence of HSV-1 infection is over 70% in industrialized nations worldwide and almost 100% in underdeveloped and undeveloped nations.
The market for herpes marker testing is growing because the herpes virus is quite widespread and doesn’t cause any symptoms. Doctors must rely on diagnostic testing to make an accurate diagnosis and administer the right treatment because more than 80% of herpes infections are asymptomatic.
Herpes simplex virus (HSV) testing, which was previously done by hand, has advanced to automated labs using advanced equipment, such as chemical analyzers, allowing for more accurate and effective testing methods. The global market for herpes testing is driven by the use of these methods.
